Latest Articles
How cyclical is Highcliff Metals Corp. (V66) stock compared to rivals - Chart Signals & Daily Market Momentum Tracking - newser.com
How cyclical is Highcliff Metals Corp. (V66) stock compared to rivals - Chart Signals & Daily Market Momentum Tracking newser.com
Published: Sept. 27, 2025, 6:30 p.m.
Analysis of the characteristics of Endometrial Fluid Samples in Recurrent Pregnancy Loss Patients based on 16S rRNA gene sequencing technology - Frontiers
Analysis of the characteristics of Endometrial Fluid Samples in Recurrent Pregnancy Loss Patients based on 16S rRNA gene sequencing technology Frontiers
Published: Sept. 27, 2025, 3:12 a.m.
ASCENT-Gyn-01 Trial of Sacituzumab Govitecan Aims to Validate Clinical Utility of TROP2 ADCs in Pretreated Endometrial Cancer - OncLive
ASCENT-Gyn-01 Trial of Sacituzumab Govitecan Aims to Validate Clinical Utility of TROP2 ADCs in Pretreated Endometrial Cancer OncLive
Published: Sept. 26, 2025, 7:40 p.m.
UNM’s Kimberly Leslie awarded $12.9M NCI grant to study endometrial cancer - The Cancer Letter
UNM’s Kimberly Leslie awarded $12.9M NCI grant to study endometrial cancer The Cancer Letter
Published: Sept. 26, 2025, 7:28 p.m.
What's the Best Method for Endometrial Cancer Surveillance? - Cancer Nursing Today
What's the Best Method for Endometrial Cancer Surveillance? Cancer Nursing Today
Published: Sept. 26, 2025, 5:47 p.m.
KU Cancer Center Evaluating Progestin Use to Treat Endometrial Cancer | Newswise - Newswise
KU Cancer Center Evaluating Progestin Use to Treat Endometrial Cancer | Newswise Newswise
Published: Sept. 26, 2025, 1:45 p.m.
What causes endometriosis? Scientists are closer to finding out - WRVO Public Media
What causes endometriosis? Scientists are closer to finding out WRVO Public Media
Published: Sept. 26, 2025, 1:22 p.m.
Ananda Pharma ends epilepsy trials, shifts focus to endometriosis drug By Investing.com - Investing.com Australia
Ananda Pharma ends epilepsy trials, shifts focus to endometriosis drug By Investing.com Investing.com Australia
Published: Sept. 26, 2025, 11:03 a.m.
Ananda Pharma ends epilepsy trials, shifts focus to endometriosis drug By Investing.com - Investing.com South Africa
Ananda Pharma ends epilepsy trials, shifts focus to endometriosis drug By Investing.com Investing.com South Africa
Published: Sept. 26, 2025, 10:56 a.m.
Ananda Pharma ends epilepsy trials, shifts focus to endometriosis drug - Investing.com India
Ananda Pharma ends epilepsy trials, shifts focus to endometriosis drug Investing.com India
Published: Sept. 26, 2025, 10:48 a.m.
Link copied to clipboard!